MedPath

ACCEL-HYOSCINE

ACCEL-HYOSCINE

Approved
DIN Number

02512335

Drug Class

Human

Market Date

Aug 19, 2021

Company
HC

accel pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02512335
AIG Number0104703001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
A03BB01 BUTYLSCOPOLAMINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification12:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

HYOSCINE BUTYLBROMIDEActive
Strength: 10 MG
Monograph: HYOSCINE BUTYLBROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.